Device Endotherapy

Single Use Grasping Forceps

Payments companies reported to CMS as associated with Single Use Grasping Forceps. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$6,895associated payments (2023-2025)
23clinicians with associated payments
2companies reporting

By year

2023 $144
2024 $2,213
2025 $4,538

Payments reported as associated with Single Use Grasping Forceps, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $6,548
Surgery $135
Gerontology (Nurse Practitioner) $88.26
Nurse Practitioner $88.25
Orthopaedic Surgery $18.26
Nurse Anesthetist, Certified Registered $17.39

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Single Use Grasping Forceps

These are the largest totals companies reported as associated with Single Use Grasping Forceps. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Gregory Haber New York, NY Gastroenterology (Internal Medicine) $3,685.00
Sergey Kantsevoy Baltimore, MD Gastroenterology (Internal Medicine) $2,176.00
Nadav Dujovny Grand Rapids, MI Surgery $116.77
Lindsay Negash Grand Rapids, MI Gastroenterology (Internal Medicine) $116.76
Matthew Moeller Grand Rapids, MI Gastroenterology (Internal Medicine) $116.76
Courtney Ferch Grand Rapids, MI Gastroenterology (Internal Medicine) $116.76
Aaron Small Aiea, HI Gastroenterology (Internal Medicine) $114.41
Tracy Griffith Peoria, AZ Gerontology (Nurse Practitioner) $88.26
Jody Pelusi Scottsdale, AZ Nurse Practitioner $88.25
Juan Echavarria San Antonio, TX Gastroenterology (Internal Medicine) $47.57

Prescribed Single Use Grasping Forceps?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.